Detalles de la búsqueda
1.
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer.
J Clin Oncol
; 17(9): 2901-8, 1999 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10561369
2.
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.
Br J Cancer
; 92(5): 820-6, 2005 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-15756252
3.
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials.
Ann Oncol
; 15(7): 1013-7, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15205193
Resultados
1 -
3
de 3
1
Próxima >
>>